Yhdistys edistää solubiologian tutkimusta, koulutusta, tiedotusta ja työpaikkojen perustamista solubiologeille harjoittaen koulutus- ja tiedotustoimintaa.
Suomen Solubiologit ry järjestää jäsenilleen kesäduuniwebinaarisarjan! 18.2.2025 pidetään sarjaan kuuluva Admescope kesäduuniwebinaari, jonka aikana kuulemme Admescopen (Oulu) kesätyöpaikoista. Webinaarin puhujana on Johanna Kontio (Business development associate, Admescope; Biolääketieteen alumni Itä-Suomen yliopistosta, Kuopiosta).
Webinaarin tiedot:
Päivänmäärä: Tiistai 18.2.2025
Aika: Klo 16-17
Paikka: Zoom
Kieli: Suomi/Englanti, yleisöstä riippuen 😊
Miksi osallistua?
Nostat mahdollisuuksiasi saada alan kesätyöpaikka!
Kuulet lisää Admescopen työtehtävistä
Pääset esittämään kysymyksiä henkilökohtaisesti Johanna Kontiolle, Admescopen edustajalle
Saat vinkkejä ja ohjeita onnistuneeseen työnhakuprosessiin
Kannattaa tulla kuulolle jo ihan senkin takia, että pääset tutustumaan alan toimijoihin ja kuulemaan hyviä vinkkejä työnhakuun!
Varmista siis paikkasi tässä webinaarissa, ja kuule lisää Admescopen työpaikoista!
***
The Finnish Society for Cell Biology is organizing a summer job webinar series for its members! On 18.2.2025, we will hold Admescope summer job webinar, where we will hear about Admescope’s summer job opportunities. The speaker of the webinar will be Johanna Kontio (Business development associate, Admescope; a biomed alumni from the University of Eastern Finland, Kuopio).
Webinar details:
Date: Tuesday 18.2.2025
Time: 16:00-17:00
Location: Zoom
Language: Finnish/English, depending on the audience 😊
Why to participate?
Increase your chances of securing a summer job in the field!
Learn more about the positions at Admescope
Get the opportunity to ask questions directly to Johanna Kontio, Admescope’s representative
Receive tips and guidance for a successful job application process
It’s worth attending just to get to know the key players in the field and hear valuable job-hunting tips!
As part of the United Nations’ annual celebration, the UEF International Day of Women and Girls in Science afternoon seminar will be organized on Tuesday 11th of February 2025, from 12:00 to 15:00 in Kuopio (SN211, Snellmania building) and remotely via Zoom!
The UEF Rector has supported this seminar, recognizing it as an initiative promoting equality and diversity within our university.
Confirmed speakers include:
Henriikka Hakomäki (Postdoctoral researcher, A.I. Virtanen Institute for Molecular Sciences, UEF)
Anna-Liisa Levonen (Professor, A.I. Virtanen Institute for Molecular Sciences, UEF)
Kirsi Ketola (Research director, Institute of Biomedicine, UEF)
Saara Hämälistö (Academy Research Fellow, University of Turku)
Enkhzaya Batnasan (Postdoctoral researcher, Institute of Biomedicine, UEF)
Anam Hammid (Postdoctoral researcher, School of Pharmacy, UEF)
Blair Rajamäki (Postdoctoral researcher, School of Pharmacy, UEF)
As part of the Nordic EMBL Partnership for Molecular Medicine, the Institute for Molecular Medicine Finland (FIMM) invites applications for
Doctoral Researchers in Molecular Medicine
We currently have 3 – 5 openings for doctoral researchers as part of the FIMM-EMBL International PhD Programme starting in August 2025 . In this interdisciplinary programme, outstanding doctoral researchers are recruited at the institute level in the scope of the main research areas at FIMM . Through the FIMM-EMBL rotation system, doctoral researchers engage in projects with 2–3 different research groups during a 6–9-month period prior to selecting a research group for their doctoral research. The program provides an exciting opportunity to explore and combine different research areas as well as to learn a variety of scientific skills and technologies while making connections within and beyond the institute.
What We Offer
An exciting opportunity to conduct impactful research in a supportive and stimulating environment.
Research training in diverse research areas and working environments with exceptional potential for collaborations.
Plenty of opportunities to attend international conferences to build scientific network.
Access to top-notch resources and excellent support to further learning and professional development.
YOUR PROFILE
Highly motivated with a second cycle academic degree ( MSc, MD or equivalent) in biology, biochemistry, bioinformatics, biotechnology, cell biology, computer science, genetics, mathematics, medicine, or other related fields, obtained before the start of the position (August 2025).
Strong analytical and quantitative skills with problem solving and troubleshooting aptitude.
Excellent written and oral communication skills in English.
Ability to work independently as well as in an international team.
How To Apply
Applications must be submitted using the University of Helsinki Recruitment System and must be accompanied by the following documents in English as a single pdf file :
Cover letter (max. 1 page) detailing motivation, research interests, and experience
Curriculum vitae (max. 3 pages including publications)
Letters of recommendation (signed by the referees) from at least 2 referees
External applicants should submit the application using the ‘Apply Now’ button below.
Internal applicants (i.e., current employees of the University of Helsinki) may submit their applications by using the “Employee Login” button.
If you need support with the recruitment system, please contact recruitment@helsinki.fi .
The application period ends on February 7, 2025 at 23:59 Eastern European Time . Please note that applications failing to meet the requirements, submitted after the deadline or with incomplete information or documents will not be considered.
SELECTION PROCESS
Application review will begin after the call has closed. Top candidates will be selected and invited for two rounds of interviews with a selection committee in the late March and early May 2025. The candidates selected for the positions will be offered an initial contract for 18 months, during the first half of which they will engage in training through 2 – 3 research group rotations . Upon a successful review and selection of a research group after the rotational period, the initial contract will be extended up to a 4-year period.
We value a diverse, equitable, and inclusive work environment. All qualified applicants will receive consideration for the position. We welcome applicants of any gender and age, linguistic or cultural background, or minority group.
Click this link to read about accessibility and inclusivity at our University.
Salary And Benefits
The salary is based on the salary system of the Finnish universities . The starting salary is typically around 2500 EUR per month and rises gradually as the PhD work progresses based on the University of Helsinki salary scheme.
The University of Helsinki provides its staff with occupational health and support for sports services as well as professional development opportunities. More information about the employee benefits at the University of Helsinki can be found at https://www.helsinki.fi/en/about-us/careers/why-university-helsinki/staff-benefits .
FURTHER INFORMATION
About the positions: FIMM’s Doctoral Training Coordinator, Rubina Tabassum ( rubina.tabassum@helsinki.fi )
Rotation programme at FIMM: https://www.helsinki.fi/en/hilife-helsinki-institute-life-science/units/fimm/training-fimm/fimm-embl-international-phd-programme
Research training at FIMM: https://www.helsinki.fi/en/hilife-helsinki-institute-life-science/units/fimm/training-fimm
Doctoral programmes at University of Helsinki: https://www.helsinki.fi/en/admissions-and-education/apply-doctoral-programmes/doctoral-school-and-doctoral-programmes
Support for International staff: https://www.helsinki.fi/en/about-us/careers/information-arriving-international-staff and https://ihhelsinki.fi/
FIMM is an international research institute focusing on human genomics and personalized medicine, and is a part of the Helsinki Institute of Life Science at the University of Helsinki . FIMM integrates molecular medicine research facilities, a technology centre, and biobanking infrastructures under one roof. FIMM promotes translational research through four “Grand Challenge” projects: Human Genomics for Health and Disease , Digital Diagnostics for Precision Medicine , Functional Precision Medicine for Cancer , and Data Science for Population Health . The research groups at FIMM cover cancer, cardiovascular disease, and neurological and psychiatric diseases in the fields of Molecular Medicine, Genomics, Molecular Bioscience, Bioinformatics, Neuroscience, Computational Biomedicine, Drug Research, Data Science, and Artificial Intelligence .
FIMM is part of the Nordic EMBL Partnership for Molecular Medicine – composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community. FIMM maintains a wealth of global partnerships with academic and industry groups, strengthened by shared appointments of several of our directors and group leaders at other top institutions, including SciLifeLab , Karolinska Institutet , and the Broad Institute of MIT and Harvard . More than half of the doctoral and postdoctoral researchers are from abroad, making FIMM a truly global community.
The University of Helsinki is a research-oriented university which offers a stimulating and international environment. The Faculty of Medicine of the University of Helsinki, together with Helsinki University Central Hospital, Helsinki Institute of Life Science, and Institute for Molecular Medicine Finland forms the Academic Medical Centre Helsinki. This medical campus ranks among the 10 best medical centres at the European level and among the 50 best centres in the world.
FIMM is an international research institute focusing on human genomics and personalized medicine, and is a part of the Helsinki Institute of Life Science at the University of Helsinki . FIMM integrates molecular medicine research facilities, a technology centre, and biobanking infrastructures under one roof. FIMM promotes translational research through four “Grand Challenge” projects: Human Genomics for Health and Disease , Digital Diagnostics for Precision Medicine , Functional Precision Medicine for Cancer , and Data Science for Population Health . The research groups at FIMM cover cancer, cardiovascular disease, and neurological and psychiatric diseases in the fields of Molecular Medicine, Genomics, Molecular Bioscience, Bioinformatics, Neuroscience, Computational Biomedicine, Drug Research, Data Science, and Artificial Intelligence .
FIMM is part of the Nordic EMBL Partnership for Molecular Medicine – composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community. FIMM maintains a wealth of global partnerships with academic and industry groups, strengthened by shared appointments of several of our directors and group leaders at other top institutions, including SciLifeLab , Karolinska Institutet , and the Broad Institute of MIT and Harvard . More than half of the doctoral and postdoctoral researchers are from abroad, making FIMM a truly global community.
The University of Helsinki is a research-oriented university which offers a stimulating and international environment. The Faculty of Medicine of the University of Helsinki, together with Helsinki University Central Hospital, Helsinki Institute of Life Science, and Institute for Molecular Medicine Finland forms the Academic Medical Centre Helsinki. This medical campus ranks among the 10 best medical centres at the European level and among the 50 best centres in the world.
Tämän vuoden ensimmäinen Solubiologi-lehti on juhlanumero, jolla juhlistetaan Suomen Solubiologit ry:n 50-vuotista taivalta. Lehdessä on mukana muun muassa Onni Sirkiän laatima artikkeli Jyväskylässä pidetystä vuosijuhlasta, yhdistyksemme kunniajäsenyyden saaneen Johanna Ivaskan Proffan suusta -kirjoitus sekä juttu Veera Luukkosen gradutyöstä, joka voitti yhdistyksemme gradupalkinnon. Kuukauden Solubiologi on juuri väitellyt Erika Naakka. Lehden kansi ja jutuissa olevat solukuvat ovat Leena Matilaisen käsialaa.
